Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Imunon, Inc. Director's Dealing 2010

Feb 23, 2010

35124_dirs_2010-02-23_d9cdb622-0311-4683-aa8e-93d4c3ec5a89.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celsion CORP (CLSN)
CIK: 0000749647
Period of Report: 2010-02-19

Reporting Person: Tardugno Michael H (Chief Executive Offier)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-02-19 Common Stock (Bonus Grant) A 17412 $2.94 Acquired 89328 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-02-19 Common Stock Option $2.94 A 85000 Acquired 2020-02-19 Celsion Common Stock (85000) Direct

Footnotes

F1: Fair Value on date of grant award.

F2: Stock Grant issued in lieu of cash bonus.

F3: Option vest 1/3 each on February 19, 2011, 2012 and 2013.